HOME >> BIOLOGY >> NEWS
Plankton are not affected by ozone depletion

The ozone hole above Antarctica may not be damaging life in the ocean below after all. If Californian researchers are right, then increased ultraviolet radiation is having scarcely any effect on the growth of marine plankton, the base of the ocean's food chain.

The team, led by Kevin Arrigo of Stanford University in Palo Alto, has created computer models of phytoplankton growth over a year in the southern hemisphere before and after the ozone hole appeared in the 1980s. They included such factors as the position of the ozone hole, cloud cover, and UV-B strength, the type of ultraviolet radiation that increases as atmospheric ozone declines.

To find out what increased UV-B did to phytoplankton, the researchers compared two models: one based on data from 1992, a year with a yawning ozone hole and the other with the same parameters except for the ozone levels, which were taken from 1978, a year of "normal" conditions before the hole appeared.

Over the southern hemisphere ecosystem as a whole, they found that primary phytoplankton production decreased by only about 1 per cent in 1992, which is significantly lower than other estimates.

Arrigo's work does not discount the results of a number of studies showing that increased UV-B can stunt phytoplankton growth by 10 per cent or more in localised areas or in the laboratory (New Scientist, 8 August 1998, p 24). The difference is that his study looked at the big picture of UV-B for the whole ocean.

In previous studies, researchers scaled up measurements of plankton growth beneath the hole and elsewhere to calculate an overall effect for the whole Southern Ocean. But although they knew that factors such as cloud cover were important, they are difficult to include in such calculations.

"On a cloudy day under a deep hole, there's still not nearly as much UV flux as on a clear day with no hole," says Arrigo. Another important factor is that, at any given time, around 80 per cent of the southern hemis
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-20-7331-2751
New Scientist
15-Feb-2000


Page: 1 2

Related biology news :

1. Plankton may influence climate change says UCSB scientist
2. Plankton power
3. Researchers Find Unexpected Feature In Plankton Nervous System
4. Seabed Silt In Indian Ocean Consists Of Remains Of Summer Plankton
5. Reading ability and ADHD affected by same genes
6. Cognitive performance influenced by gene for prion protein (also affected by mad cow disease)
7. Researchers discover important genetic flaw in family affected by schizophrenia
8. Alzheimers protein jams mitochondria of affected cells; resulting energy crisis kills neurons
9. Plant pathologists find growing number of plants affected by sudden oak death
10. Hydroxyurea therapy improves survival in most severely affected sickle cell patients
11. Scientists find grass yield, carbon storage not affected by creepy-crawlies in the soil

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Plankton are not affected ozone depletion

(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... Dec. 9, 2014  Wake Forest Baptist Medical Center today ... its School of Medicine. Funding for this $50 million ... that will be publicly launched next summer. ... the former 60 series R.J. Reynolds Tobacco Company complex, ... will begin immediately with plans to be ready to ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/19/2014)... The empty capsules market is experiencing growth ... technological innovations in the empty capsules market. The ... growth of the empty capsules market. , Get ... of Report , The report will enrich both ... to gauge the pulse of the market which ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and science ... Huntsworth Health Group, is proud to announce the addition ... role, Gonzales will serve as Senior Vice President of ... welcome a talent of Jamie’s caliber to the Audacity ... is a proven healthcare innovation leader and brand management ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: